Approval · Notice of Compliance 14034 · 2013
PENTASA: Notice of Compliance 14034
Issued January 21, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14034
- Date
- January 21, 2013
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASA | 02399466 | Marketed |
Medicinal ingredients
- MESALAZINE 1 G per TAB